Bioinformatic Analysis of Neuroimmune Mechanism of Neuropathic Pain
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 4516349
Abstract
Background. Neuropathic pain (NP) is a devastating complication following nerve injury, and it can be alleviated by regulating neuroimmune direction. We aimed to explore the neuroimmune mechanism and identify some new diagnostic or therapeutic targets for NP treatment via bioinformatic analysis. Methods. The microarray GSE18803 was downloaded and analyzed using R. The Venn diagram was drawn to find neuroimmune‐related differentially expressed genes (DEGs) in neuropathic pain. Gene Ontology (GO), pathway enrichment, and protein‐protein interaction (PPI) network were used to analyze DEGs, respectively. Besides, the identified hub genes were submitted to the DGIdb database to find relevant therapeutic drugs. Results. A total of 91 neuroimmune‐related DEGs were identified. The results of GO and pathway enrichment analyses were closely related to immune and inflammatory responses. PPI analysis showed two important modules and 8 hub genes: PTPRC, CD68, CTSS, RAC2, LAPTM5, FCGR3A, CD53, and HCK. The drug‐hub gene interaction network was constructed by Cytoscape, and it included 24 candidate drugs and 3 hub genes. Conclusion. The present study helps us better understand the neuroimmune mechanism of neuropathic pain and provides some novel insights on NP treatment, such as modulation of microglia polarization and targeting bone resorption. Besides, CD68, CTSS, LAPTM5, FCGR3A, and CD53 may be used as early diagnostic biomarkers and the gene HCK can be a therapeutic target.Keywords
Funding Information
- Natural Science Foundation of Tianjin Municipality (19JCZDJC36300)
- National Natural Science Foundation of China (81930070, 81871766, 81772342, 81620108018)
This publication has 53 references indexed in Scilit:
- Infant nerve injury induces delayed microglial polarization to the M1 phenotype, and exercise reduces delayed neuropathic pain by modulating microglial activityNeuroscience, 2017
- Spared Nerve Injury Increases the Expression of Microglia M1 Markers in the Prefrontal Cortex of Rats and Provokes Depression-Like BehaviorsFrontiers in Neuroscience, 2017
- Alendronate Attenuates Spinal Microglial Activation and Neuropathic PainThe Journal of Pain, 2016
- Pathological pain and the neuroimmune interfaceNature Reviews Immunology, 2014
- Treatment Options in Paraneoplastic Disorders of the Peripheral Nervous SystemCurrent Treatment Options in Neurology, 2013
- Hck Tyrosine Kinase Regulates TLR4-Induced TNF and IL-6 Production via AP-1The Journal of Immunology, 2011
- Dominance of E. coli phagocytosis over LPS in the inflammatory response of microgliaJournal of Neuroimmunology, 2010
- Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNFαNeuroscience Letters, 2008
- Inhibition of spinal microglial cathepsin S for the reversal of neuropathic painProceedings of the National Academy of Sciences, 2007
- Activation of a novel microglial gene encoding a lysosomal membrane protein in response to neuronal apoptosisMolecular Brain Research, 2001